Brexanolone is a medication used in the treatment of postpartum depression in adult women. It is in the GABA-A modulator class of medications. This activity describes the indications, contraindications, pharmacodynamics, pharmacokinetics, and monitoring for brexanolone as a valuable agent in treating postpartum depression. This activity reviews information for brexanolone pertinent for members of the interprofessional team in the treatment of patients with postpartum depression.

**Objectives:**
- Outline the indications for brexanolone.
- Describe the dosing of brexanolone. 
- Identify the most common adverse effects of brexanolone therapy.
- Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by postpartum depression.